How to Help Your Patients Save Money on Leqvio: A Provider's Guide to Savings Programs

Cost is one of the most significant barriers to Leqvio (inclisiran) adoption — not because the drug is broadly inaccessible, but because many patients and providers are unfamiliar with how coverage and savings programs work for physician-administered specialty drugs. This guide gives prescribers a practical, actionable framework for helping patients access Leqvio affordably in 2026.

Understanding How Leqvio Is Covered: Medical Benefit, Not Pharmacy Benefit

This is the single most important distinction for providers to understand:

Leqvio is covered under the medical benefit (Part B-like), not the pharmacy benefit (Part D).

Because Leqvio is administered in your office, it is billed using HCPCS code J1306 under the medical benefit — similar to how vaccines, infusions, and other in-office injectables are billed. This means:

• Patients' pharmacy deductibles and drug formulary tiers don't apply.
• Coverage is typically more favorable than specialty pharmacy tiers.
• 92% of patients with insurance have confirmed medical benefit coverage for Leqvio, per Novartis data.

What Most Patients Actually Pay for Leqvio

Understanding the real-world cost picture helps you set accurate patient expectations:

• 75% of commercial insurance patients pay less than $10 per injection
• Over 50% of commercial insurance patients pay $0
• Medicare patients with Medigap supplemental insurance often pay $0
• Medicare Part B covers 80% after the Part B deductible ($257 in 2025)

Savings Program 1: The Leqvio Co-Pay Program (Commercial Insurance)

Eligible patients with commercial insurance can enroll in the Leqvio Co-Pay Program to pay as little as $0 per treatment. No financial documentation is required to enroll. The program may include a co-pay card, payment card, or rebate, depending on the patient's plan.

Provider action: Enroll patients during or immediately after the PA submission process. Enrollment can be completed by your staff through leqvio.com or by calling the Leqvio Service Center at 1-833-537-8462. Build this into your Leqvio initiation workflow.

Exclusions: The Co-Pay Program is not available to patients enrolled in Medicare, Medicaid, or any federal healthcare program.

Savings Program 2: Novartis Patient Assistance Foundation (Uninsured / Underinsured)

For patients who are uninsured or underinsured and cannot afford Leqvio, the Novartis Patient Assistance Foundation can provide the drug at no charge to eligible patients. Eligibility is income-based.

Application process: Apply at pap.novartis.com or through the Leqvio Service Center (1-833-537-8462). Documentation includes income verification and a completed physician attestation form. Prescription medication is shipped to the practice, not the patient.

Savings Program 3: Medicare Part B Coverage

Medicare generally covers Leqvio under Part B as a physician-administered drug (HCPCS code J1306). There is no National Coverage Determination (NCD), but Medicare pays for drugs administered incident to a physician's service.

Provider considerations for Medicare patients:

• Verify coverage under the patient's specific Medicare Advantage plan (coverage varies by plan)
• Check for step therapy requirements — some Medicare Advantage plans require prior statin therapy before covering Leqvio
• Advise Medicare patients with Medigap supplemental insurance that their coinsurance (20% after Part B deductible) may be covered by their supplement plan
• Refer Medicare patients who face access issues to the Novartis Patient Assistance Foundation for potential assistance

Building an Efficient Leqvio Access Workflow in Your Practice

The most effective practices have a systematic workflow for Leqvio initiation. Consider this sequence:

1. Decision to prescribe → Confirm patient eligibility (diagnosis, LDL-C, statin history)
2. Insurance check → Verify medical benefit coverage and PA requirements through the Leqvio Service Center or payer portal
3. PA submission → Submit immediately with complete documentation (diagnosis, LDL-C, statin history)
4. Savings program enrollment → Enroll in Co-Pay Program (commercial) or refer to PAF (Medicare/uninsured) before first dose
5. Order drug → Order through your specialty distributor once PA is approved
6. Schedule appointments → Book all three initial appointments (Day 1, Month 3, Month 9) at the start

How medfinder Supports Your Patient Access Efforts

When patients need to find an administering provider outside your practice, medfinder for providers can locate clinics near the patient with Leqvio in stock. This reduces patient dropout from access barriers and keeps adherence high — critical for a medication that requires scheduled semi-annual injections to maintain LDL-C control.

For more on prior authorization strategy, see our provider guide to Leqvio availability and PA navigation in 2026.